The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoo, W. S.
Right arrow Articles by Kranz, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoo, W. S.
Right arrow Articles by Kranz, D. M.

The Journal of Immunology, Vol 150, Issue 10 4331-4337, Copyright © 1993 by American Association of Immunologists


ARTICLES

Role of CD8 in staphylococcal enterotoxin B-mediated lysis by cytotoxic T lymphocytes

WS Hoo and DM Kranz
Department of Biochemistry, University of Illinois, Urbana 61801.

Recent evidence has suggested that recognition of superantigens such as the staphylococcal enterotoxins by CTL occurs independently of the accessory molecule CD8. These conclusions are based on the observation that antibodies to CD8 do not appear to be effective inhibitors of T cell lysis that is mediated by enterotoxin. This is in contrast to the well-known inhibitory effects of anti-CD8 antibodies on T cell activation by most peptide/class I complexes. In this study, we show that lysis of staphylococcus enterotoxin B (SEB)-bearing target cells by the mouse alloreactive CTL clone 2C is inhibited by anti-CD8 antibodies. SEB-mediated lysis by a polyclonal population of mouse CTL was also inhibited by anti-CD8 antibodies, but only under conditions where the SEB concentration is low. Inhibition occurs even when class I negative Daudi cells are used as targets. Thus, the observed inhibition does not appear to be due to the prevention of intercellular interactions between CD8 and class I molecules but is probably a consequence of preventing the intracellular association of CD8 and TCR. At the high ligand densities used in most previous studies, very few of the CD8/TCR complexes may be required for activation. Under these conditions, lysis may appear to be CD8 "independent" because 1) there are a sufficient number of preexisting CD8/TCR complexes for activation; or 2) prohibitively high concentrations of antibody would be needed to saturate unassociated CD8.


This article has been cited by other articles:


Home page
J. Immunol.Home page
L. Wooldridge, S. L. Hutchinson, E. M. Choi, A. Lissina, E. Jones, F. Mirza, P. R. Dunbar, D. A. Price, V. Cerundolo, and A. K. Sewell
Anti-CD8 Antibodies Can Inhibit or Enhance Peptide-MHC Class I (pMHCI) Multimer Binding: This Is Paralleled by Their Effects on CTL Activation and Occurs in the Absence of an Interaction between pMHCI and CD8 on the Cell Surface
J. Immunol., December 15, 2003; 171(12): 6650 - 6660.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. A. Zapata, A. Pacheco-Castro, P. S. Torres, A. R. Ramiro, E. San Jose, B. Alarcon, L. Alibaud, B. Rubin, M. L. Toribio, and J. R. Regueiro
Conformational and Biochemical Differences in the TCR{middle dot}CD3 Complex of CD8+ Versus CD4+ Mature Lymphocytes Revealed in the Absence of CD3gamma
J. Biol. Chem., December 3, 1999; 274(49): 35119 - 35128.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. K. Cho, B. A. Schodin, and D. M. Kranz
Characterization of a Single-chain Antibody to the beta-Chain of the T Cell Receptor
J. Biol. Chem., October 27, 1995; 270(43): 25819 - 25826.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.